Rosalía Demetrio‐Pablo
Marqués de Valdecilla University Hospital(ES)
Publications by Year
Research Areas
Ocular Diseases and Behçet’s Syndrome, Retinal and Optic Conditions, Systemic Lupus Erythematosus Research, Sarcoidosis and Beryllium Toxicity Research, Vasculitis and related conditions
Most-Cited Works
- → Anti–Interleukin‐6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis–Associated Uveitis Refractory to Anti–Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty‐Five Patients(2016)150 cited
- → Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients(2019)111 cited
- → Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases(2019)106 cited
- → Anti-interleukin 6 receptor tocilizumab in refractory uveitis associated with Behçet’s disease: multicentre retrospective study(2018)104 cited
- → Anti-IL-6 Receptor Tocilizumab in Refractory Graves’ Orbitopathy: National Multicenter Observational Study of 48 Patients(2020)81 cited
- → Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease(2018)66 cited
- → Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review(2016)46 cited
- → Biologic therapy in severe and refractory peripheral ulcerative keratitis (PUK). Multicenter study of 34 patients(2020)41 cited
- → Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behçet Disease: National Study of 103 White Patients(2020)28 cited
- → Systemic treatment in sarcoidosis: Experience over two decades(2022)25 cited